Deep vein thrombosis

Reading File
Finding Sources
Searching PubMed

"deep vein thrombosis"[MeSH Terms] AND diagnosis AND management

Searching Images

deep vein thrombosis DVT pathophysiology diagram

This composite educational graphic illustrates the two-point compression technique for point-of-care ultrasound (POCUS) assessment of deep vein thrombosis (DVT). Panel A is an anatomical diagram of the lower extremities showing the placement of the ultrasound transducer at the common femoral vein (groin level) and the popliteal vein (popliteal fossa). Panels B and C are transverse grayscale B-mode ultrasound images of a vein (marked by yellow arrows) adjacent to an artery. Image B displays the vein in its resting state, appearing as a rounded, anechoic lumen. Image C demonstrates the same vein under external transducer compression; the vessel walls are fully apposed, resulting in complete collapse of the lumen. This visual finding—total venous compressibility—is the primary diagnostic indicator for the absence of intraluminal thrombus. The content is designed for medical professionals and students learning bedside ultrasound protocols for vascular assessment.

This composite educational graphic illustrates the two-point compression technique for point-of-care ultrasound (POCUS) assessment of deep vein thrombosis (DVT). Panel A is an anatomical diagram of the lower extremities showing the placement of the ultrasound transducer at the common femoral vein (groin level) and the popliteal vein (popliteal fossa). Panels B and C are transverse grayscale B-mode ultrasound images of a vein (marked by yellow arrows) adjacent to an artery. Image B displays the vein in its resting state, appearing as a rounded, anechoic lumen. Image C demonstrates the same vein under external transducer compression; the vessel walls are fully apposed, resulting in complete collapse of the lumen. This visual finding—total venous compressibility—is the primary diagnostic indicator for the absence of intraluminal thrombus. The content is designed for medical professionals and students learning bedside ultrasound protocols for vascular assessment.

This medical infographic describes a 'Vein-Chip' microphysiological system designed to model endotheliopathy and venous thrombosis in the context of COVID-19. The visual is divided into several sections: an anatomical illustration showing SARS-CoV-2 entry via the respiratory tract, leading to vascular effects in the lower limbs; a comparative diagram of a 'Healthy' human vein versus one with 'Vein thrombosis,' highlighting the obstruction of the vessel lumen and valve architecture by a thrombotic mass; and a Venn diagram illustrating the interplay between ACE2-YAP/TAZ signaling, fluid dynamics, and blood components in vessel wall pathology. Technical diagrams detail the organ-on-a-chip engineering, including a 3D microfluidic device (25mm x 20mm) with specific valve geometry. The bottom right features high-resolution diagnostic imagery: a fluorescence micrograph (200 µm scale) showing endothelial cell junctions (green) and nuclei (blue) within the microvessel, and a scanning electron micrograph (SEM) providing a detailed view of the 3D endothelium and blood cell interactions. This educational resource is intended for advanced biomedical research and hematology studies, focusing on the pathophysiology of Deep Vein Thrombosis (DVT) and viral-induced vascular injury.

This medical infographic describes a 'Vein-Chip' microphysiological system designed to model endotheliopathy and venous thrombosis in the context of COVID-19. The visual is divided into several sections: an anatomical illustration showing SARS-CoV-2 entry via the respiratory tract, leading to vascular effects in the lower limbs; a comparative diagram of a 'Healthy' human vein versus one with 'Vein thrombosis,' highlighting the obstruction of the vessel lumen and valve architecture by a thrombotic mass; and a Venn diagram illustrating the interplay between ACE2-YAP/TAZ signaling, fluid dynamics, and blood components in vessel wall pathology. Technical diagrams detail the organ-on-a-chip engineering, including a 3D microfluidic device (25mm x 20mm) with specific valve geometry. The bottom right features high-resolution diagnostic imagery: a fluorescence micrograph (200 µm scale) showing endothelial cell junctions (green) and nuclei (blue) within the microvessel, and a scanning electron micrograph (SEM) providing a detailed view of the 3D endothelium and blood cell interactions. This educational resource is intended for advanced biomedical research and hematology studies, focusing on the pathophysiology of Deep Vein Thrombosis (DVT) and viral-induced vascular injury.

A pathophysiology diagram illustrating the dual pathways leading to thromboembolic and bleeding complications in COVID-19. The schematic begins with a SARS-CoV-2 virion triggering endothelial damage and macrophage infection via angiotensin-II (AT2) receptors. In the 'Early (first week)' phase, endothelial damage leads to the release of von Willebrand factor (VWF), factor VIII (FVIII), and angiopoietin-2, which activate the coagulation cascade and tissue factor, resulting in thrombus formation. This pathway culminates in an increased prevalence of thromboembolic events, including venous thromboembolism (VTE), pulmonary embolism (PE), deep vein thrombosis (DVT), in situ thrombosis, arterial thrombosis, and microthrombosis. Simultaneously, infected macrophages and immune cells trigger an inflammatory response (cytokine storm). In the later phase (>6-14 days), prolonged immune and inflammatory responses lead to the consumption of coagulation factors, thrombocytopenia, and platelet dysfunction. This secondary pathway results in an increased incidence of bleedings, such as disseminated intravascular coagulopathy (DIC), intraparenchymatous/intraluminal bleedings, and subcutaneous hematomas.

A pathophysiology diagram illustrating the dual pathways leading to thromboembolic and bleeding complications in COVID-19. The schematic begins with a SARS-CoV-2 virion triggering endothelial damage and macrophage infection via angiotensin-II (AT2) receptors. In the 'Early (first week)' phase, endothelial damage leads to the release of von Willebrand factor (VWF), factor VIII (FVIII), and angiopoietin-2, which activate the coagulation cascade and tissue factor, resulting in thrombus formation. This pathway culminates in an increased prevalence of thromboembolic events, including venous thromboembolism (VTE), pulmonary embolism (PE), deep vein thrombosis (DVT), in situ thrombosis, arterial thrombosis, and microthrombosis. Simultaneously, infected macrophages and immune cells trigger an inflammatory response (cytokine storm). In the later phase (>6-14 days), prolonged immune and inflammatory responses lead to the consumption of coagulation factors, thrombocytopenia, and platelet dysfunction. This secondary pathway results in an increased incidence of bleedings, such as disseminated intravascular coagulopathy (DIC), intraparenchymatous/intraluminal bleedings, and subcutaneous hematomas.

This composite educational graphic details a 3-point point-of-care ultrasound (POCUS) protocol for diagnosing deep vein thrombosis (DVT) in the lower extremities. Panel A contains an anatomical diagram of the left leg venous system, labeling the common iliac, external iliac, common femoral, greater saphenous, deep femoral, superficial femoral, and popliteal veins. It illustrates three primary scanning sites: Site 1 (S1) covering the common femoral vein to the greater saphenous bifurcation; Site 2 (S2) covering the proximal superficial and deep femoral segments; and Site 3 (S3) covering the popliteal vein to the trifurcation. Panel B shows a transverse B-mode diagnostic ultrasound image of the right inguinal region. The image demonstrates a common femoral artery (CFA) adjacent to a common femoral vein (CFV). The CFV appears non-compressible with internal hyperechoic material, indicative of an acute venous thrombus. This visual comparison highlights the key POCUS diagnostic criteria for DVT: non-compressibility of the venous lumen under probe pressure. This material is designed for medical training in emergency medicine and vascular radiology.

This composite educational graphic details a 3-point point-of-care ultrasound (POCUS) protocol for diagnosing deep vein thrombosis (DVT) in the lower extremities. Panel A contains an anatomical diagram of the left leg venous system, labeling the common iliac, external iliac, common femoral, greater saphenous, deep femoral, superficial femoral, and popliteal veins. It illustrates three primary scanning sites: Site 1 (S1) covering the common femoral vein to the greater saphenous bifurcation; Site 2 (S2) covering the proximal superficial and deep femoral segments; and Site 3 (S3) covering the popliteal vein to the trifurcation. Panel B shows a transverse B-mode diagnostic ultrasound image of the right inguinal region. The image demonstrates a common femoral artery (CFA) adjacent to a common femoral vein (CFV). The CFV appears non-compressible with internal hyperechoic material, indicative of an acute venous thrombus. This visual comparison highlights the key POCUS diagnostic criteria for DVT: non-compressibility of the venous lumen under probe pressure. This material is designed for medical training in emergency medicine and vascular radiology.

Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Loading Image
Loading Image
I now have comprehensive information from multiple authoritative textbooks. Here is a thorough, well-organized answer on DVT.

Deep Vein Thrombosis (DVT)

DVT is the formation of a thrombus within the deep venous system, most commonly in the lower extremities. It is part of the broader spectrum of venous thromboembolism (VTE), which also includes pulmonary embolism (PE). When untreated, proximal propagation of thrombus causes PE in up to one-third of hospitalized patients, and untreated lower extremity DVT carries a 30% recurrence rate. - Sabiston Textbook of Surgery, p. 2415

Anatomy

The deep venous system of the leg spans from the distal calf veins (posterior tibial, anterior tibial, peroneal) through the popliteal, femoral, and deep femoral veins, continuing to the common femoral, external and common iliac veins, and ultimately the inferior vena cava.
Leg vein anatomy relevant to DVT - ROSEN's Emergency Medicine
Fig: Diagram of leg vein anatomy relevant to DVT. A three-point ultrasound includes the common femoral, femoral, and popliteal veins. A whole-leg ultrasound adds the greater saphenous, posterior tibial, peroneal, and gastrocnemius veins. - ROSEN's Emergency Medicine

Pathophysiology (Virchow's Triad)

Three major factors predispose to thrombosis - Gray's Anatomy for Students, p. 785:
  1. Venous stasis - reduced or stagnant blood flow (immobility, reduced calf pump, obstruction)
  2. Endothelial injury - venous trauma damages vessel walls and promotes thrombus formation
  3. Hypercoagulability - abnormal levels of clotting factors, such as antithrombin III, protein C, and protein S

Risk Factors

CategoryExamples
Surgical/ProceduralMajor pelvic, orthopaedic (hip/knee replacement), abdominal surgery
ImmobilityProlonged bed rest (≥3 days), plaster immobilization, paralysis
Patient factorsActive cancer, prior DVT, pregnancy, older age
Hypercoagulable statesFactor V Leiden, protein C/S deficiency, antiphospholipid syndrome
Device-relatedCentral venous catheter, pacemaker leads (upper extremity DVT)
Left leg DVT occurs slightly more often because the left iliac vein is vulnerable to compression by the left iliac artery - this is May-Thurner syndrome. Bilateral leg DVT is found in fewer than 10% of ED patients. - ROSEN's Emergency Medicine, p. 1196

Clinical Features

Hallmarks include unilateral limb pain and swelling, though findings can be subtle and nonspecific. Patients may report only mild cramping or a sense of fullness in the calf.
Signs include:
  • Edema, erythema, warmth of the affected extremity
  • Tenderness to palpation along the deep venous distribution
  • Dilation of superficial collateral veins
  • Rarely: a palpable venous cord
  • Homans' sign (calf pain on dorsiflexion) - neither sensitive nor specific
  • Most DVTs show no physical signs at all
Clinical photo: (A) Left leg DVT with marked swelling vs. (B) Ruptured Baker cyst - note the clinically similar appearance. - ROSEN's Emergency Medicine
Note the similar clinical appearance of DVT (left panel) vs. ruptured Baker cyst (right panel) - highlighting why clinical signs alone are insufficient.
For upper extremity DVT: >90% occur with an indwelling catheter. Without a device, upper extremity DVT tends to occur in the dominant arm of young athletes - Paget-Schroetter syndrome (effort-induced thoracic outlet syndrome). - ROSEN's Emergency Medicine, p. 1196

Differential Diagnosis

  • Venous insufficiency / chronic venous congestion
  • Cellulitis (concurrent DVT in a patient with cellulitis is only ~3%)
  • Muscle or tendon injury (gastrocnemius tear, Achilles injury)
  • Baker cyst (including rupture)
  • Spontaneous calf muscle hematoma
  • Asymmetric edema from heart failure or liver disease
  • Arterial insufficiency/claudication

Diagnostic Approach

Step 1: Pre-test Probability - Wells Score

The Two-Level DVT Wells Score is the standard tool: - Bailey & Love's Surgery, p. 345
Clinical FeaturePoints
Active cancer (treatment ongoing, within 6 months, or palliative)+1
Paralysis, paresis, or recent plaster immobilization of lower extremities+1
Recently bedridden ≥3 days OR major surgery within 12 weeks+1
Localized tenderness along distribution of the deep venous system+1
Entire leg swollen+1
Calf swelling ≥3 cm larger than asymptomatic side+1
Pitting edema confined to the symptomatic leg+1
Collateral superficial veins (non-varicose)+1
Previously documented DVT+1
Alternative diagnosis at least as likely as DVT-2
Interpretation:
  • ≥2 points: DVT likely - proceed to compression ultrasound
  • ≤1 point: DVT unlikely - perform D-dimer first

Step 2: D-dimer

  • A negative D-dimer in a low-probability patient effectively rules out DVT
  • D-dimer has high sensitivity but low specificity - a positive result requires imaging

Step 3: Imaging

Compression duplex ultrasound is the primary imaging modality. Non-compressibility of the venous lumen under probe pressure is the key diagnostic criterion.
  • Proximal DVT (popliteal vein and above): Well-detected by 2-point or 3-point compression protocol
  • Distal (calf) DVT: Requires whole-leg ultrasound - if proximal veins are normal but pre-test probability is high, repeat ultrasound in 1 week to detect proximal propagation
The POCUS 3-point protocol scans: Common femoral vein (S1), superficial/deep femoral junction (S2), and popliteal vein to trifurcation (S3).

Management

Anticoagulation

Initiate immediately upon diagnosis (or even before imaging if high pre-test probability and delay expected). - ROSEN's Emergency Medicine, p. 1199
Initial options:
  • LMWH (e.g., enoxaparin) - subcutaneous, does not require monitoring; preferred bridge
  • Unfractionated heparin (UFH) IV - if rapid reversal needed; target PTT 60-80 sec (anti-Xa 0.3-0.7 units/mL); initial bolus 80 units/kg or 5000 units
  • Rivaroxaban or apixaban - can be started directly (no LMWH bridge needed)
Long-term oral anticoagulation:
Drug ClassExamplesKey Notes
DOACs - Factor Xa inhibitorsRivaroxaban, apixaban, edoxabanFirst-choice per ACCP; no INR monitoring; fewer bleeds vs. warfarin
DOACs - Direct thrombin inhibitorsDabigatranRequires LMWH lead-in
Vitamin K antagonistWarfarinINR target 2-3; requires monitoring; teratogenic
LMWHEnoxaparinPreferred in pregnancy and cancer
DOACs are as effective as warfarin for preventing recurrent VTE with fewer bleeding events, especially intracranial bleeding. Rivaroxaban and apixaban do not require LMWH bridging. - ROSEN's Emergency Medicine, p. 1199

Duration of Anticoagulation

DVT TypeDuration
Provoked (surgery, trauma, immobility)3 months
Unprovoked (no identifiable cause)3-6 months; re-evaluate benefit/risk of extended therapy at 3 months
Recurrent DVT, active cancer, hereditary hypercoagulable stateIndefinite (lifelong)
Cancer-associated DVTLMWH preferred; DOACs also acceptable (non-inferior for up to 6 months)
PregnancyLMWH throughout - warfarin and DOACs contraindicated
Upper extremity DVTStandard 3-month course

Special Situations

Isolated calf vein DVT: Controversial. About 15% will propagate proximally if untreated. Favor anticoagulation with: ongoing thrombotic risk, severe symptoms, DVT >5 cm, proximity to proximal veins, or prior VTE. High bleeding risk favors serial surveillance ultrasound instead.
Superficial vein thrombophlebitis: If the greater saphenous vein clot extends above the knee, a 45-day prophylactic-dose course reduces progression. If within 3 cm of the femoral junction, therapeutic anticoagulation for at least 30 days is warranted.
Phlegmasia cerulea dolens / alba dolens: Massive iliofemoral occlusion causing entire leg swelling with venous ischemia (blue/pale, painful leg). This is a limb-threatening emergency requiring catheter-directed thrombolysis (CDT), percutaneous thrombectomy, or surgical thrombectomy. Transfer to a capable center immediately if resources unavailable. - ROSEN's Emergency Medicine, p. 1201

IVC Filter

Placed when anticoagulation is absolutely contraindicated (uncontrollable active bleeding, acute hemorrhagic stroke, severe thrombocytopenia, polytrauma with solid organ/intracranial injury). Permanent filters are associated with long-term complications including IVC occlusion and recurrent DVT. - Goldman-Cecil Medicine

Catheter-Directed Thrombolysis (CDT)

Accelerates thrombus resolution and increases patency vs. anticoagulation alone. The ATTRACT trial found no difference in overall outcomes, but there may be benefit for large iliofemoral clot burden. A Cochrane review showed reduction in post-thrombotic syndrome with CDT. Risk of increased bleeding is a key concern. - Current Surgical Therapy 14e

Complications

ComplicationDetails
Pulmonary embolism (PE)Leading complication; small emboli cause pleuritic chest pain; large emboli can be fatal; proximal propagation occurs in up to 1/3 of hospitalized patients
Post-thrombotic syndrome (PTS)Chronic venous insufficiency: leg swelling, pain, venous hypertension, skin pigmentation, induration, ulceration - Miller's Review of Orthopaedics
Recurrent DVT~30% untreated; recurrence risk 4x higher with prior DVT
PhlegmasiaLimb-threatening massive venous occlusion (described above)
Chronic thromboembolic pulmonary hypertension (CTEPH)Long-term complication of PE/DVT

Prophylaxis in High-Risk Surgical Patients

Risk stratification by procedure type - Bailey & Love's Surgery:
  • Low risk: Maxillofacial, neurosurgery, cardiothoracic
  • Medium risk: Abdominal, gynecological, urological, inguinal hernia
  • High risk: Pelvic elective/trauma surgery, total hip/knee replacement
Measures:
  • Compression stockings (avoid in peripheral arterial disease, neuropathy, severe edema, leg deformity)
  • Intermittent pneumatic compression (calf pumps)
  • LMWH (pharmacological prophylaxis)
  • Risk assessment within 24 hours of admission; review if clinical situation changes

Key Pearls

  • The clinical diagnosis of DVT is unreliable - always use Wells score + D-dimer/ultrasound
  • Bilateral DVT is uncommon (<10%) - consider alternative diagnoses
  • DOACs (especially rivaroxaban/apixaban) are now the first-choice anticoagulants for most patients
  • Warfarin and DOACs are contraindicated in pregnancy - use LMWH
  • Homans' sign is neither sensitive nor specific
  • A high-probability Wells score with negative proximal ultrasound still warrants repeat ultrasound at 1 week (to catch distal DVT propagation)

Sources: ROSEN's Emergency Medicine (9780323757898); Bailey and Love's Short Practice of Surgery 28e (9780367548117); Sabiston Textbook of Surgery (9780443124341); Current Surgical Therapy 14e (9780323796835); Gray's Anatomy for Students (9780323934237); Goldman-Cecil Medicine (9780323930345); Miller's Review of Orthopaedics 9e (9780443112140)
This is a shared conversation. Sign in to Orris to start your own chat.